K-numberK251075
Device nameDYNAMIS™ Implant System
ApplicantPromethean Restorative, LLC
Product codeOUR
Device classClass II
Decision dateApr 25, 2025
DecisionSubstantially Equivalent
Regulation888.3040
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The DYNAMIS™ Implant System is a sacroiliac joint fusion device consisting of threaded, fenestrated, cannulated, 3D-printed titanium alloy implants and associated instruments. It is indicated for sacroiliac joint fusion in cases of joint dysfunction, disruption, and degenerative sacroiliitis, as well as for pelvic fracture fixation. Two or more implants are inserted across the sacroiliac joint to provide stabilization and fusion while allowing packing of bone graft materials.

Technological characteristics

The system features fully threaded, lag-design cannulated implants in multiple diameters and lengths, manufactured from medical-grade titanium alloy (Ti-6Al-4V ELI per ASTM F3001). A key distinguishing feature is the DYNAMIS™ TRU-NANO Screw variant, which incorporates a micro- and nano-roughened surface with electrochemically treated nanotube arrays (pore diameter 30–97 nanometers) incorporating calcium and phosphate, designed to promote osteoblast and mesenchymal stem cell mineralization.

Test standards cited

Testing was conducted per ASTM F3574 (static and dynamic cantilever bending), ASTM F543 (static axial pullout, static torsion, and driving torque), and AAMI ST72:2011 (bacterial endotoxin testing). In vitro evaluations quantitated extracellular matrix mineralization by osteoblasts and mesenchymal stem cells on titanium alloy substrates.

Substantial equivalence argument

The device is substantially equivalent because it shares the same intended use (sacroiliac joint fusion and pelvic fracture fixation), similar design (threaded metallic fasteners for bone fixation), comparable materials (titanium alloy), and equivalent function to the predicate devices. Performance testing demonstrates mechanical equivalence in strength and integrity. The nanotextured surface modification, while novel, does not alter the fundamental predicate function but rather enhances it through proven biological mechanisms without changing the device's classification or use.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →